Physician profile
Lori E Rousche
NPI 1275588691
$715.69
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $95.96 · 2021: $149 · 2022: $127 · 2023: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $188.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $130.39 | 2019-2021 | |
| Abbvie INC. | $91.84 | 2021-2023 | Vraylar |
| Pfizer INC. | $86.39 | 2019-2023 | |
| Glaxosmithkline, LLC. | $66.31 | 2022-2023 | Pediarix, Bexsero, Menveo |
| Daiichi Sankyo INC. | $62.05 | 2020-2023 | Injectafer |
| Amgen INC. | $50.91 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.80 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $28.23 | 2023 | Rexulti |
| Astrazeneca Pharmaceuticals Lp | $26.62 | 2022 | |
| Alexion Pharmaceuticals, INC. | $16.47 | 2021 | |
| Sanofi Pasteur INC. | $15.36 | 2020 | |
| Lilly USA, LLC | $15.22 | 2023 | Mounjaro |
| Eisai INC. | $14.32 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.09 | 2023 | Xifaxan |
| Esperion Therapeutics, INC. | $13.80 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $12.57 | 2019 | |
| Merck Sharp & Dohme LLC | $12.08 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.12 | 2021 | |
| Allergan, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Rousche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.